Tag Archives: LDN
Research: Potential therapeutic benefit of Low Dose Naltrexone in ME/CFS
Potential Therapeutic Benefit of Low Dose Naltrexone in Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome: role of Transient Receptor Potential Melastatin 3 Ion channels in pathophysiology and treatment, by Helene Cabanas, Katsuhiko Muraki, Natalie Eaton-Fitch, Donald Ross Staines and Sonya Marshall-Gradisnik in … Continue reading
Posted in News
Tagged Dr Sonya Marshall-Gradisnik, Hélène Cabanas, Katsuhiko Muraki, LDN, low dose naltrexone, Natalie Eaton-Fitch, Natural Killer cells, Patch Clamp electrophysiology, Prof Donald Staines, Transient receptor potential Melastatin 3, TRPM3 ion channel function
Comments Off on Research: Potential therapeutic benefit of Low Dose Naltrexone in ME/CFS
Low-dose naltrexone in the treatment of ME/CFS
Low-dose naltrexone in the treatment of myalgic encephalomyelitis/ chronic fatigue syndrome (ME/CFS), by Olli Polo, Pia Pesonen, Essi Tuominen in Fatigue: Biomedicine, Health & Behavior Nov 19, 2019 [doi/full/10.1080/21641846.2019.1692770] Research abstract: Background: Myalgic encephalomyelitis (ME)/chronic fatigue syndrome (CFS) is … Continue reading
Posted in News
Tagged drug safety, Essi Tuominen, LDN, low dose naltrexone, Olli Polo, Pia Pesonen
Comments Off on Low-dose naltrexone in the treatment of ME/CFS
